Opus Genetics

  • BioTech/Drugs
  • Durham NC
  • 17 employees
Employee Directory Email Format Management Departments
Get Full Info

Company Overview

Website
opusgtx.com
Employees
17
Founded in
2021
Industry
BioTech/Drugs
More Details

Financials & Stats

Revenue

$10B

More Financials

Recent News & Media

Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Jul 3, 2025
  • globenewswire.com

Opus Genetics Reveals Major Equity Package: 240K Options, 150K RSUs for Key Gene Therapy Talent

  • Jul 3, 2025
  • stocktitan.net

Viatris, Opus Genetics’ Investigational Phentolamine Ophthalmic Solution Demonstrates Strong Results in Presbyopia Trial

  • Jul 1, 2025
  • pharmexec.com

Opus Genetics' VEGA-3 presbyopia trial meets endpoints for phentolamine 0.75%

  • Jul 1, 2025
  • glance.eyesoneyecare.com

Processa hands cancer candidate back to Opus Genetics after deciding milestone out of reach

  • Jul 1, 2025
  • fiercebiotech.com

Retinal Degeneration Fund providing funding to Opus Genetics to support OPGx-MERTK program

  • Jun 28, 2025
  • ophthalmologytimes.com

Who is Opus Genetics

Opus Genetics is a clinical-stage gene therapy company headquartered in Durham, North Carolina. The company is privately held and employs 17 individuals. Opus Genetics specializes in developing innovative treatments for inherited retinal diseases. Opus Genetics focuses on gene therapy programs for a range of inherited retinal diseases. Their approach combines deep understanding of patient needs with a portfolio of wholly owned programs. The company is dedicated to delivering groundbreaking therapies to patients suffering from these debilitating conditions. Opus Genetics stands out due to its unique model and unwavering commitment to patient needs. Backed by the RD Fund, the venture arm of Foundation Fighting Blindness, Opus Genetics benefits from a strong partnership dedicated to advancing research and treatment options for inherited retinal diseases. For more information about Opus Genetics and their gene therapy programs, please visit their website at opusgtx.com.

Company Leadership

Ben Yerxa

Chief Executive Officer

Phone Email
Jason Menzo

Co-Founder

Phone Email
Peter Ginsberg

Co-Founder

Phone Email
Kristie Hamby

Director, Program Management

Phone Email

Companies Similar to Opus Genetics

Analyze industry trends and opportunities by examining competitors and companies comparable to Opus Genetics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.

Company Name Revenue Number of Employees Location Founded in

Astria Therapeutics Inc

 10M 59 Boston, MA

Eleven Biotherapeutics

 10M 27 Cambridge, MA 2010

Interleukin Genetics

 10M 23 Waltham, MA 1999

MetaStat

 10M 2 Boston, MA

Yield10 Bioscience

 10M 46 Woburn, MA
View More Companies

FAQ

What is the location of Opus Genetics's headquarters?
The headquarters of Opus Genetics are situated at 8 Davis Drive, Suite 220, Durham NC
What is Opus Genetics's official website?
The official website of Opus Genetics can be found at opusgtx.com.
What is Opus Genetics's current revenue?
As of June 2024, Opus Genetics's annual revenue reached $10B.
How many employees does Opus Genetics currently have?
Opus Genetics employs approximately 17+ people as of June 2024
Which industries is Opus Genetics primarily operating in?
Opus Genetics operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
Who is the Chief Executive Officer of Opus Genetics?
Opus Genetics's Chief Executive Officer is Ben Yerxa
When was Opus Genetics founded?
Opus Genetics was founded in 2021.

Employee Directory

Key Employees

Ben Yerxa

President & CEO

Phone Email

Ashwath Jayagopal

Chief Scientific Officer

Phone Email

Sarah Tuller

Chief Regulatory Officer

Phone Email